Pluri (PLUR) EBIT Margin (QoQ) (2011 - 2025)
Pluri (PLUR) EBIT Margin (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -127,636.00 |
| Sep 30, 2025 | -34,593.00 |
| Jun 30, 2025 | -39,893.00 |
| Mar 31, 2025 | 141,482.00 |
| Dec 31, 2024 | -108,498.00 |
| Sep 30, 2024 | 469,094.00 |
| Jun 30, 2024 | 150,895.00 |
| Mar 31, 2024 | -282,960.00 |
| Dec 31, 2023 | 499,265.00 |
| Sep 30, 2023 | -406,191.00 |
| Jun 30, 2023 | 226,542.00 |
| Mar 31, 2023 | 32.58 Mn |
| Dec 31, 2022 | -32.60 Mn |
| Dec 31, 2018 | 20.76 Mn |
| Dec 31, 2015 | 566,005.00 |
| Dec 31, 2014 | -71,368.00 |
| Sep 30, 2014 | 122,254.00 |
| Jun 30, 2014 | 263,430.00 |
| Mar 31, 2014 | -241,789.00 |
| Dec 31, 2013 | -224,211.00 |